'Godfather of AI' Geoffrey Hinton on Regrets Over Inventing AI: Calls for FDA-Like Rules Before Releasing Models, Says Public Pressure Like Climate Ch...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Ray Dalio Says AI Bubble Is ‘Close’ to Bursting as Debt and Rising Rates Raise Red Flags...
Intel CEO Lip-Bu Tan Says Company Will Keep Working on Terafab — Elon Musk Confirms TSMC May Only Sublease Part of the Fab, Not Own It...
Robinhood's Investment Chief Says She Prefers Owning Energy Stocks Over ETFs — Should These Stocks Be on Your Radar?...
IBM Ready Partners With SAP Solutions To Help Customers Accelerate Cloud ERP Modernization, Unify Enterprise Data, And Establish An AI-Ready Digital C...
Cantor Fitzgerald Maintains Overweight on Travelers Companies, Raises Price Target to $378...
EQT, UnitedHealth, Clearway Energy And More On CNBC’s ‘Final Trades’...
Reported Oct. 6: 'Apple to Launch Doorbell, Lock, Thermostat Developed With LG' - Bloomberg...
Tempus Announces Expanded Collaboration With Merck And Moderna For Potential Commercialization Of Cancer Vaccine Intismeran Autogene; Terms Not Disclo...
Jim Cramer Says Investors Are Overlooking Elon Musk’s $40 Billion ‘Pot of Gold’ For Nvidia — Intel Terafab Exit Rumors ‘Squashed,’ Dismisses ‘Weakness...
Chevron Swaps Hess Midstream Stake for 50% Lower Bakken Costs — and a $200 Million Payment...
Most Undervalued Chip Stocks In October 2026: Four Are Cheaper Than The S&P 500...
Evercore ISI Group Maintains Outperform on Microsoft, Raises Price Target to $635...
Guggenheim Reiterates Buy on Johnson & Johnson, Maintains $287 Price Target...
These Analysts Boost Their Forecasts On Zscaler...
Nvidia Inside: Microsoft's New Laptop Runs AI Agents Without the Cloud...
Halozyme Says Dutch Court Upholds Its Patent, Bars Merck From Making And Selling Keytruda SC In Multiple European Markets...
Reported October 6, FCC Approves SpaceX NGSO MSS System For Direct-To-Device Services...
Cisco Launches Agentic Partnership...
Morgan Stanley Maintains Equal-Weight on Amgen, Lowers Price Target to $359...